These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Cunningham K; Lacy DB; Mogridge J; Collier RJ Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439 [TBL] [Abstract][Full Text] [Related]
7. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Moayeri M; Wiggins JF; Leppla SH Infect Immun; 2007 Nov; 75(11):5175-84. PubMed ID: 17724066 [TBL] [Abstract][Full Text] [Related]
8. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. Arora N; Leppla SH J Biol Chem; 1993 Feb; 268(5):3334-41. PubMed ID: 8429009 [TBL] [Abstract][Full Text] [Related]
9. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869 [TBL] [Abstract][Full Text] [Related]
10. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Varughese M; Teixeira AV; Liu S; Leppla SH Infect Immun; 1999 Apr; 67(4):1860-5. PubMed ID: 10085028 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Brossier F; Sirard JC; Guidi-Rontani C; Duflot E; Mock M Infect Immun; 1999 Feb; 67(2):964-7. PubMed ID: 9916116 [TBL] [Abstract][Full Text] [Related]
12. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity. Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978 [TBL] [Abstract][Full Text] [Related]
13. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency. Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550 [TBL] [Abstract][Full Text] [Related]
14. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. Singh Y; Chaudhary VK; Leppla SH J Biol Chem; 1989 Nov; 264(32):19103-7. PubMed ID: 2509473 [TBL] [Abstract][Full Text] [Related]
15. Role of toxin functional domains in anthrax pathogenesis. Brossier F; Weber-Levy M; Mock M; Sirard JC Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564 [TBL] [Abstract][Full Text] [Related]
16. Residue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor. Cao S; Guo A; Wu G; Liu Z; Chen W; Feng C; Zhang CC; Chen H J Bacteriol; 2010 Nov; 192(21):5799-805. PubMed ID: 20833809 [TBL] [Abstract][Full Text] [Related]
17. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437 [TBL] [Abstract][Full Text] [Related]